NIST has updated the NVD program announcement page with additional information regarding recent concerns and the temporary delays in enrichment efforts.
CVE-2021-34998 DetailDescriptionThis vulnerability allows local attackers to escalate privileges on affected installations of Panda Security Free Antivirus 20.2.0.0. An attacker must first obtain the ability to execute low-privileged code on the target system in order to exploit this vulnerability. The specific flaw exists within the use of named pipes. The issue results from allowing an untrusted process to impersonate the client of a pipe. An attacker can leverage this vulnerability to escalate privileges and execute arbitrary code in the context of SYSTEM. Was ZDI-CAN-14208. Severity
CVSS 4.0 Severity and Metrics:
NVD Analysts use publicly available information to associate vector strings and CVSS scores. We also display any CVSS information provided within the CVE List from the CNA. Note: NVD Analysts have not published a CVSS score for this CVE at this time. NVD Analysts use publicly available information at the time of analysis to associate CVSS vector strings. References to Advisories, Solutions, and ToolsBy selecting these links, you will be leaving NIST webspace. We have provided these links to other web sites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other web sites that are more appropriate for your purpose. NIST does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, NIST does not endorse any commercial products that may be mentioned on these sites. Please address comments about this page to nvd@nist.gov.
Weakness Enumeration
Known Affected Software Configurations Switch to CPE 2.2CPEs loading, please wait.
Denotes Vulnerable Software Quick InfoCVE Dictionary Entry:CVE-2021-34998 NVD Published Date: 01/13/2022 NVD Last Modified: 01/20/2022 Source: Zero Day Initiative |